nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—UGT1A1—urine—adrenal gland cancer	0.072	0.217	CbGeAlD
Flunitrazepam—CYP2C19—urine—adrenal gland cancer	0.039	0.118	CbGeAlD
Flunitrazepam—UGT2B7—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0339	0.0524	CbGpPWpGaD
Flunitrazepam—CYP1A2—urine—adrenal gland cancer	0.0319	0.0962	CbGeAlD
Flunitrazepam—CYP2C9—urine—adrenal gland cancer	0.0302	0.0913	CbGeAlD
Flunitrazepam—CYP2E1—urine—adrenal gland cancer	0.0287	0.0865	CbGeAlD
Flunitrazepam—UGT1A1—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0276	0.0426	CbGpPWpGaD
Flunitrazepam—GABRA6—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0252	0.039	CbGpPWpGaD
Flunitrazepam—GABRA4—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0249	0.0385	CbGpPWpGaD
Flunitrazepam—CYP3A4—urine—adrenal gland cancer	0.0231	0.0696	CbGeAlD
Flunitrazepam—GABRA5—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0221	0.0342	CbGpPWpGaD
Flunitrazepam—GABRA3—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0217	0.0336	CbGpPWpGaD
Flunitrazepam—GABRA2—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0214	0.033	CbGpPWpGaD
Flunitrazepam—GABRA1—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0182	0.0282	CbGpPWpGaD
Flunitrazepam—CYP2A6—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.0158	0.0244	CbGpPWpGaD
Flunitrazepam—GABRA4—pituitary gland—adrenal gland cancer	0.015	0.0453	CbGeAlD
Flunitrazepam—UGT1A3—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.0132	0.0203	CbGpPWpGaD
Flunitrazepam—TSPO—adrenal cortex—adrenal gland cancer	0.0131	0.0397	CbGeAlD
Flunitrazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0116	0.0179	CbGpPWpGaD
Flunitrazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0115	0.0177	CbGpPWpGaD
Flunitrazepam—TSPO—gonad—adrenal gland cancer	0.0109	0.0329	CbGeAlD
Flunitrazepam—TSPO—cardiac atrium—adrenal gland cancer	0.0109	0.0328	CbGeAlD
Flunitrazepam—TSPO—pituitary gland—adrenal gland cancer	0.0106	0.0321	CbGeAlD
Flunitrazepam—GABRA2—adrenal gland—adrenal gland cancer	0.0103	0.0309	CbGeAlD
Flunitrazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0102	0.0157	CbGpPWpGaD
Flunitrazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00999	0.0155	CbGpPWpGaD
Flunitrazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00982	0.0152	CbGpPWpGaD
Flunitrazepam—TSPO—adrenal gland—adrenal gland cancer	0.00949	0.0287	CbGeAlD
Flunitrazepam—UGT1A1—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00909	0.0141	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00872	0.0135	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00861	0.0133	CbGpPWpGaD
Flunitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00837	0.013	CbGpPWpGaD
Flunitrazepam—CYP2B6—adrenal cortex—adrenal gland cancer	0.00809	0.0244	CbGeAlD
Flunitrazepam—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00779	0.012	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00765	0.0118	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00751	0.0116	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00738	0.0114	CbGpPWpGaD
Flunitrazepam—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00701	0.0108	CbGpPWpGaD
Flunitrazepam—CYP2B6—gonad—adrenal gland cancer	0.0067	0.0202	CbGeAlD
Flunitrazepam—GABRA6—Neuronal System—KCNJ5—adrenal gland cancer	0.00668	0.0103	CbGpPWpGaD
Flunitrazepam—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—adrenal gland cancer	0.00668	0.0103	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—KCNJ5—adrenal gland cancer	0.0066	0.0102	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0063	0.00974	CbGpPWpGaD
Flunitrazepam—Ketazolam—ABCB1—adrenal gland cancer	0.00597	0.27	CrCbGaD
Flunitrazepam—GABRA5—Neuronal System—KCNJ5—adrenal gland cancer	0.00586	0.00906	CbGpPWpGaD
Flunitrazepam—CYP2B6—adrenal gland—adrenal gland cancer	0.00584	0.0176	CbGeAlD
Flunitrazepam—GABRA3—Neuronal System—KCNJ5—adrenal gland cancer	0.00576	0.0089	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—KCNJ5—adrenal gland cancer	0.00566	0.00875	CbGpPWpGaD
Flunitrazepam—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00565	0.00874	CbGpPWpGaD
Flunitrazepam—CYP2E1—adrenal gland—adrenal gland cancer	0.00548	0.0166	CbGeAlD
Flunitrazepam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00539	0.00833	CbGpPWpGaD
Flunitrazepam—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00527	0.00816	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—KCNJ5—adrenal gland cancer	0.00482	0.00746	CbGpPWpGaD
Flunitrazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00445	0.00687	CbGpPWpGaD
Flunitrazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00439	0.00679	CbGpPWpGaD
Flunitrazepam—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00427	0.00661	CbGpPWpGaD
Flunitrazepam—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00426	0.00659	CbGpPWpGaD
Flunitrazepam—Clobazam—ABCB1—adrenal gland cancer	0.00422	0.191	CrCbGaD
Flunitrazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0039	0.00603	CbGpPWpGaD
Flunitrazepam—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.0039	0.00602	CbGpPWpGaD
Flunitrazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00383	0.00592	CbGpPWpGaD
Flunitrazepam—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.00382	0.0059	CbGpPWpGaD
Flunitrazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00376	0.00582	CbGpPWpGaD
Flunitrazepam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00371	0.00574	CbGpPWpGaD
Flunitrazepam—Nitrazepam—ABCB1—adrenal gland cancer	0.00349	0.158	CrCbGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00334	0.00517	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.0033	0.0051	CbGpPWpGaD
Flunitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00321	0.00496	CbGpPWpGaD
Flunitrazepam—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00317	0.0049	CbGpPWpGaD
Flunitrazepam—Flurazepam—ABCB1—adrenal gland cancer	0.0031	0.14	CrCbGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00294	0.00455	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00293	0.00453	CbGpPWpGaD
Flunitrazepam—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00291	0.0045	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00288	0.00445	CbGpPWpGaD
Flunitrazepam—Midazolam—ABCB1—adrenal gland cancer	0.00287	0.13	CrCbGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00283	0.00438	CbGpPWpGaD
Flunitrazepam—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.00264	0.00408	CbGpPWpGaD
Flunitrazepam—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00257	0.00397	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—PRKACA—adrenal gland cancer	0.00256	0.00396	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—PRKACA—adrenal gland cancer	0.00253	0.00391	CbGpPWpGaD
Flunitrazepam—Diazepam—ABCB1—adrenal gland cancer	0.00246	0.111	CrCbGaD
Flunitrazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00245	0.00378	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00241	0.00373	CbGpPWpGaD
Flunitrazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.0024	0.0037	CbGpPWpGaD
Flunitrazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00237	0.00366	CbGpPWpGaD
Flunitrazepam—CYP2A6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00236	0.00364	CbGpPWpGaD
Flunitrazepam—UGT1A3—Biological oxidations—POMC—adrenal gland cancer	0.00235	0.00363	CbGpPWpGaD
Flunitrazepam—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00235	0.00363	CbGpPWpGaD
Flunitrazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.0023	0.00355	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—PRKACA—adrenal gland cancer	0.00225	0.00347	CbGpPWpGaD
Flunitrazepam—CYP2A6—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.00223	0.00344	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—PRKACA—adrenal gland cancer	0.00221	0.00341	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—PRKACA—adrenal gland cancer	0.00217	0.00335	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—SDHB—adrenal gland cancer	0.0021	0.00325	CbGpPWpGaD
Flunitrazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.0021	0.00325	CbGpPWpGaD
Flunitrazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00206	0.00319	CbGpPWpGaD
Flunitrazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00203	0.00314	CbGpPWpGaD
Flunitrazepam—UGT2B7—Biological oxidations—POMC—adrenal gland cancer	0.002	0.00309	CbGpPWpGaD
Flunitrazepam—CYP2B6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.0019	0.00294	CbGpPWpGaD
Flunitrazepam—CYP2E1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00186	0.00288	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—PRKACA—adrenal gland cancer	0.00185	0.00286	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.0018	0.00278	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—SDHB—adrenal gland cancer	0.00179	0.00276	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00178	0.00275	CbGpPWpGaD
Flunitrazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00177	0.00274	CbGpPWpGaD
Flunitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00173	0.00267	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.00166	0.00256	CbGpPWpGaD
Flunitrazepam—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00164	0.00253	CbGpPWpGaD
Flunitrazepam—UGT1A1—Biological oxidations—POMC—adrenal gland cancer	0.00162	0.00251	CbGpPWpGaD
Flunitrazepam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00162	0.0025	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00158	0.00244	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00155	0.0024	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00152	0.00236	CbGpPWpGaD
Flunitrazepam—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00149	0.00231	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—SDHB—adrenal gland cancer	0.00145	0.00225	CbGpPWpGaD
Flunitrazepam—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00144	0.00222	CbGpPWpGaD
Flunitrazepam—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00138	0.00214	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—BRAF—adrenal gland cancer	0.00138	0.00213	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00138	0.00213	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.00136	0.00211	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—BRAF—adrenal gland cancer	0.00136	0.00211	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00136	0.0021	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—SDHD—adrenal gland cancer	0.00135	0.00209	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—RRM1—adrenal gland cancer	0.00135	0.00209	CbGpPWpGaD
Flunitrazepam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00131	0.00203	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.0013	0.00201	CbGpPWpGaD
Flunitrazepam—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00127	0.00197	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—POMC—adrenal gland cancer	0.00125	0.00194	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—BRAF—adrenal gland cancer	0.00121	0.00187	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00121	0.00187	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—BRAF—adrenal gland cancer	0.00119	0.00184	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00119	0.00183	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—BRAF—adrenal gland cancer	0.00117	0.00181	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00117	0.0018	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—SDHD—adrenal gland cancer	0.00115	0.00178	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—RRM1—adrenal gland cancer	0.00115	0.00178	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00115	0.00177	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00112	0.00173	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—SDHB—adrenal gland cancer	0.00112	0.00173	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00112	0.00173	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.0011	0.0017	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00109	0.00169	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00108	0.00167	CbGpPWpGaD
Flunitrazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00107	0.00165	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—POMC—adrenal gland cancer	0.00101	0.00156	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—MED12—adrenal gland cancer	0.00101	0.00156	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—BRAF—adrenal gland cancer	0.000996	0.00154	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000994	0.00154	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—POMC—adrenal gland cancer	0.000989	0.00153	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000979	0.00151	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.000966	0.00149	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.000966	0.00149	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000961	0.00149	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000961	0.00149	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000945	0.00146	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000943	0.00146	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—RRM1—adrenal gland cancer	0.000936	0.00145	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—SDHD—adrenal gland cancer	0.000936	0.00145	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000927	0.00143	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—SDHB—adrenal gland cancer	0.000903	0.0014	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—SDHB—adrenal gland cancer	0.000885	0.00137	CbGpPWpGaD
Flunitrazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000864	0.00134	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—MED12—adrenal gland cancer	0.000859	0.00133	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000806	0.00125	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00079	0.00122	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.000763	0.00118	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PRKACA—adrenal gland cancer	0.000737	0.00114	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000736	0.00114	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—RRM1—adrenal gland cancer	0.000721	0.00112	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—SDHD—adrenal gland cancer	0.000721	0.00112	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—MED12—adrenal gland cancer	0.000698	0.00108	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.000696	0.00108	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.000683	0.00106	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000671	0.00104	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PRKACA—adrenal gland cancer	0.000626	0.000969	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.000622	0.000962	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—GNAS—adrenal gland cancer	0.000597	0.000923	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	0.000595	0.00092	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—ABCB1—adrenal gland cancer	0.000586	0.000906	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—SDHD—adrenal gland cancer	0.000582	0.0009	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—RRM1—adrenal gland cancer	0.000582	0.0009	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000574	0.000887	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—SDHD—adrenal gland cancer	0.00057	0.000882	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—RRM1—adrenal gland cancer	0.00057	0.000882	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—MED12—adrenal gland cancer	0.000538	0.000832	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000537	0.000831	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SDHB—adrenal gland cancer	0.000532	0.000822	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PRKACA—adrenal gland cancer	0.000509	0.000787	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—GNAS—adrenal gland cancer	0.000508	0.000785	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—ABCB1—adrenal gland cancer	0.000498	0.00077	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00049	0.000757	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000459	0.00071	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.00044	0.00068	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.00044	0.00068	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—MED12—adrenal gland cancer	0.000434	0.000671	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—MED12—adrenal gland cancer	0.000425	0.000657	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000419	0.000647	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—GNAS—adrenal gland cancer	0.000413	0.000638	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.00041	0.000635	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—ABCB1—adrenal gland cancer	0.000405	0.000626	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—POMC—adrenal gland cancer	0.000402	0.000622	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000401	0.00062	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000401	0.00062	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PRKACA—adrenal gland cancer	0.000392	0.000607	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SDHD—adrenal gland cancer	0.000343	0.00053	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—RRM1—adrenal gland cancer	0.000343	0.00053	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—POMC—adrenal gland cancer	0.000342	0.000529	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.000328	0.000507	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PTGS2—adrenal gland cancer	0.000321	0.000496	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GNAS—adrenal gland cancer	0.000318	0.000492	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	0.000317	0.00049	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ABCB1—adrenal gland cancer	0.000312	0.000483	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	0.00031	0.000479	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000299	0.000462	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000293	0.000453	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—POMC—adrenal gland cancer	0.000278	0.00043	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PTGS2—adrenal gland cancer	0.000273	0.000422	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000267	0.000413	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000264	0.000409	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000264	0.000409	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GNAS—adrenal gland cancer	0.000257	0.000397	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—MED12—adrenal gland cancer	0.000256	0.000395	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	0.000252	0.000389	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GNAS—adrenal gland cancer	0.000251	0.000389	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	0.000247	0.000381	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	0.000239	0.00037	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000234	0.000362	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000228	0.000353	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTGS2—adrenal gland cancer	0.000222	0.000343	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.000218	0.000337	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—POMC—adrenal gland cancer	0.000214	0.000331	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000213	0.00033	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000197	0.000305	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GNAS—adrenal gland cancer	0.000194	0.0003	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	0.00019	0.000294	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	0.000186	0.000288	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000182	0.000282	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000177	0.000273	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000173	0.000268	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—POMC—adrenal gland cancer	0.000173	0.000267	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTGS2—adrenal gland cancer	0.000171	0.000264	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—POMC—adrenal gland cancer	0.000169	0.000262	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GNAS—adrenal gland cancer	0.000151	0.000234	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	0.000148	0.000229	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000144	0.000222	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	0.000138	0.000213	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	0.000135	0.000209	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—POMC—adrenal gland cancer	0.000131	0.000202	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—POMC—adrenal gland cancer	0.000119	0.000184	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000117	0.00018	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000114	0.000177	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	0.000104	0.000161	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—POMC—adrenal gland cancer	0.000102	0.000157	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	9.49e-05	0.000147	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	8.11e-05	0.000125	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—POMC—adrenal gland cancer	7.85e-05	0.000121	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	6.26e-05	9.68e-05	CbGpPWpGaD
